What to Know About Monoclonal Antibody Treatment
COVID-19 has understandably become a part of our everyday lives and conversations. With its commonplace in the media, it has quickly become a topic of varying opinions and perspectives that subsequently leave many confused. There is a lot to know when it comes to vaccines and treatments, and we have positive news concerning the latter.
Optimistically, due to the distribution of vaccines, the U.S. has made great strides in preventing the spread of the virus. Many hospitals are reporting less stress on their bed availability, fewer people are contracting the virus, and most reported cases of vaccinated individuals are not ending up with severe symptoms that lead to hospitalization.
Aside from the efforts of vaccinations, the other front of this battle is the treatment for those who test positive with COVID-19 or its variants. This is where monoclonal antibody treatment comes into play.
What Is Monoclonal Antibody Treatment?
Monoclonal antibody technology is a technique of infusing specific, fast-replicating myeloma cells with immune cells that contain the genetic code for the countering antibody of a particular virus. In turn, after natural replication of these hybrid cells, what is left are very specific antibody immune cells that are armed to fight off the specified virus. This provides your body with a boost to your immune system to fight off a particular disease, often resulting in little-to-no symptomatic reactions to exposure or infection by disease.
Treatment Accreditation and Approval
Monoclonal antibody technology isn’t necessarily new. Despite this, its application in the current pandemic is a cutting-edge treatment and is proving time and time again to safely be the future of many treatments to come.
With its use against COVID-19, some may still concern themselves about the safety and efficacy of this application. Although this fear can be natural, the technique has been used, tested, and refined over 20 years, so you can rest assured of its efficiency. In addition, because the version that was specified for the treatment of COVID-19 has gone through several trials with positive results, the FDA recently approved its use.
Who is the Treatment Meant For?
Being only recently approved, the use of this treatment is not widely accessible and has only been approved for the use in “…mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients, including neonates…” Although this treatment can be used for preventative measures, it is only currently approved for post-exposure/infection treatment.
In addition to currently being a post-infection treatment, it is ideally administered earlier, 10 days from the onset of symptoms. The further outside of this window administration takes place, the less effective the treatment may be. Because of this, it is key for those who qualify for this treatment to consult with their doctor early on to provide the best chance of success.
How Elevated Health is Helping the Cause
Here at Elevated Health, our medical staff is up to date with the most current, cutting-edge information regarding your health. The treatment of COVID-19 and related concerns are no exceptions. Our doctors are ready and confident to provide you with the best path to ensure your loved ones are kept safe, healthy, and strong––especially during this difficult pandemic.
At Elevated Health, we officially offer monoclonal antibody treatment to anyone who qualifies for it. If you have further questions or hesitations, please reach out to our team. We’re happy to explain what this recent development means for you and how it will work.
